Search
Returning search results with filters:
Remove filter for
Category: Health product
Remove filter for
Issue: COVID
Clear all
Type
Audience
Category
Issue
Last updated
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 3 of 3 items.
… On July 27, 2020, Health Canada authorized VEKLURY® (remdesivir) with conditions to treat COVID-19 in adults and … of this product in Canada, Health Canada has added Remdesivir from the US intended for clinical trials with … for Canadian patients ahead of the Canadian-labelled VEKLURY being marketed. Healthcare professionals are advised …
AlertHealth professional risk communication | 2020-09-15
… â Health Canada has authorized with conditions the drug remdesivir (brand name Veklury) manufactured by Gilead Sciences Canada, Inc. for the … pneumonia and require extra oxygen to help them breathe. Remdesivir is the first drug that Health Canada has …
AlertPublic advisory | 2020-07-28
… granted authorization with conditions for the use of Veklury (remdesivir) to treat COVID-19 in patients with pneumonia requiring supplemental oxygen. Remdesivir is the first drug to be authorized in Canada for …
AlertInformation update | 2020-04-25